Literature DB >> 23179941

Endoscopic dacryocystorhinostomy: outcomes using mucosal flap preserving technique.

Ibrahim Çukurova1, Gül Caner Mercan, Erdem Çetinkaya, Murat Gümüsssoy, Hakan Söken.   

Abstract

Currently, transnasal approaches are preferred widely for treating chronic dacryocystitis. Restenosis which count for the most common causes of failure in endoscopic dacryocystorhinostomy (EDCR) reduces the success rate. We intended to make a large fistula, potentially minimizing granulation tissue, and synechiae by means of creating a large bony ostium and preserving mucosal flaps and intubation with silicone tube (STI). In this study, long-term follow-up results of EDCR with mucosa preservation were discussed. 126 patients underwent endonasal DCRs from January 2004 to March 2009. A large ostium was created preserving mucosa; nasal and lacrimal flaps were approximated and the new ostium was stented with silicone tube. Surgical success rate was 93 % with STI and with preservation of nasal and lacrimal flaps. In conclusion, EDCR is an easy surgical procedure with low complication rates. Intranasal pathologies can also be corrected in the meantime. Success depends on creating a large bony ostium and preventing restenosis. EDCR preserving nasal and lacrimal flaps with STI is recommended as an alternative procedure in chronic dacryocystitis with high success rates.

Entities:  

Mesh:

Year:  2012        PMID: 23179941     DOI: 10.1007/s00405-012-2285-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

Review 1.  Dacryocystorhinostomy. Diagnosis and treatment of nasolacrimal canal obstructions.

Authors:  M Onerci
Journal:  Rhinology       Date:  2002-06       Impact factor: 3.681

2.  Tricompartment model of the lacrimal pump mechanism.

Authors:  B B Becker
Journal:  Ophthalmology       Date:  1992-07       Impact factor: 12.079

3.  Endoscopic laser-assisted lacrimal surgery.

Authors:  R S Gonnering; D B Lyon; J C Fisher
Journal:  Am J Ophthalmol       Date:  1991-02-15       Impact factor: 5.258

4.  Powered endoscopic dacryocystorhinostomy.

Authors:  Peter John Wormald
Journal:  Laryngoscope       Date:  2002-01       Impact factor: 3.325

5.  Double stent intubations in difficult post-traumatic dacryocystorhinostomy.

Authors:  J J Hurwitz; K F Archer; J S Gruss
Journal:  Ophthalmic Surg       Date:  1988-01

6.  Study of intranasal ostium external dacryocystorhinostomy.

Authors:  J V Linberg; R L Anderson; R M Bumsted; R Barreras
Journal:  Arch Ophthalmol       Date:  1982-11

7.  The prognostic value of preoperative dacryocystography in endoscopic intranasal dacryocystorhinostomy.

Authors:  G E Mannor; A L Millman
Journal:  Am J Ophthalmol       Date:  1992-02-15       Impact factor: 5.258

8.  Modified endoscopic dacryocystorhinostomy with posterior lacrimal sac flap for nasolacrimal duct obstruction.

Authors:  K S C Yuen; L Y M Lam; M W Y Tse; D D N Chan; B W C Wong; W M Chan
Journal:  Hong Kong Med J       Date:  2004-12       Impact factor: 2.227

9.  Adjunctive use of mitomycin C on endoscopic lacrimal surgery.

Authors:  G Zilelioğlu; S H Uğurbaş; Y Anadolu; M Akiner; T Aktürk
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

10.  Endonasal dacryocystorhinostomy with mucosal flaps.

Authors:  Angelo Tsirbas; Peter J Wormald
Journal:  Am J Ophthalmol       Date:  2003-01       Impact factor: 5.258

View more
  2 in total

1.  Nasolacrimal duct mucocele: case report and literature review.

Authors:  Fernanda Carneiro Corujeira de Britto; Vitor Veloso Rosier; Tovar Vicente Luz; Raquel Crisóstomo Lima Verde; Clara Mônica Figueiredo de Lima; Marcus Miranda Lessa
Journal:  Int Arch Otorhinolaryngol       Date:  2014-02-13

2.  A Modified Preserved Nasal and Lacrimal Flap Technique in Endoscopic Dacryocystorhinostomy.

Authors:  Wenyan Peng; Bowei Tan; Yandong Wang; Haiying Wang; Zhonghao Wang; Xuanwei Liang
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.